Upside Endeavors, a medical communications company, proposed the idea for this supplement to the Cleveland Clinic Journal of Medicine and assisted in its development by suggesting and/or recruiting authors and by providing editorial assistance to some authors. Upside Endeavors’ contributions to specific articles are detailed on the opening page of each article. The Journal’s two guest editors for this supplement approved the selection of article topics and authors, and all manuscripts were independently peer reviewed by the guest editors.
The editors and authors of this supplement were asked to disclose any relationships or financial interests that could be perceived as a potential conflict of interest in the context of their contributions to this supplement. Their disclosures were as follows:
- Alpesh N. Amin, MD, MBA,
has received honoraria from Wyeth Pharmaceuticals for writing, as well as fees for serving on speakers’ bureaus for Wyeth, Ortho-McNeil Pharmaceutical, Pfizer Inc., and Cubist Pharmaceuticals.
- Thomas M. File, Jr, MD,
received an honorarium, which he donated to a memorial fund, from Wyeth Pharmaceuticals for preparation of his article.
- Morton P. Goldman, PharmD, BCPS,
has received fees for serving on speakers’ bureaus for Enzon Pharmaceuticals, Wyeth Pharmaceuticals, Abbott Laboratories, Schering-Plough Corp., Forest Laboratories, and Pfizer Inc., and has received honoraria for writing from Wyeth.
- Mark A. Malangoni, MD,
has received research grant support and honoraria for writing or speaking from Wyeth Pharmaceuticals.
- James I. Merlino, MD,
has received honoraria from Wyeth Pharmaceuticals for writing or speaking.
- Radhika Nair, PhD,
receives a salary from Abbott Laboratories (her current employer) and has received honoraria for writing from Wyeth.
- Susan J. Rehm, MD,
has received research grant support from Cubist Pharmaceuticals; consulting/advisory fees from Cubist, Wyeth Pharmaceuticals, and Schering-Plough Corp.; and fees or honoraria for speaking and writing from Cubist and Wyeth.
- Louis B. Rice, MD,
has received consulting/advisory fees from Wyeth Pharmaceuticals, Elan Corp., Merck & Co., Novexel, and Johnson & Johnson and has received honoraria from Wyeth and Elan for speaking or writing.
- John A. Weigelt, MD,
has received research grant support, consulting/advisory fees, and honoraria for speaking or writing from Pfizer Inc., Wyeth Pharmaceuticals, Schering-Plough Corp., and Ortho-McNeil Pharmaceutical.
|
